Stocks To Buy - Pharma

Highlighted as a stock to watch due to its promising obesity candidate, MariTide , which offers a potentially less frequent dosing schedule than existing competitors. Top Income & Stability Picks

Continues to be a top pick for 2026 due to the explosive demand for Zepbound and Mounjaro . Analysts at JPMorgan view Lilly as a preferred large-cap name with significant volume growth potential. pharma stocks to buy

A dominant player in the GLP-1 space alongside Lilly. The anticipated launch of its Wegovy pill in early 2026 is expected to unlock massive volume and maintain its leadership in obesity care. Highlighted as a stock to watch due to

As of April 2026, the pharmaceutical sector is characterized by aggressive competition in , significant merger and acquisition (M&A) activity , and strategic shifts to mitigate the impact of the Inflation Reduction Act (IRA) and "Most Favored Nation" pricing. Investors seeking to build a pharma portfolio should consider a mix of high-growth leaders and stable, high-yield dividend payers. Top Growth Picks (GLP-1 & Innovation) A dominant player in the GLP-1 space alongside Lilly